title: Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
authors.affiliation: Clinic of Internal Medicine V-Nephrology/Transplantation, University Hospital Charité, Humboldt-University Berlin, Federal Republic of Germany.
authors.forename: P
authors.initials: P
authors.lastname: Reinke
authors.forename: F
authors.initials: F
authors.lastname: Kern
authors.forename: E
authors.initials: E
authors.lastname: Fietze
authors.forename: W D
authors.initials: WD
authors.lastname: Döcke
authors.forename: R
authors.initials: R
authors.lastname: Ewert
authors.forename: F
authors.initials: F
authors.lastname: Emmrich
authors.forename: H D
authors.initials: HD
authors.lastname: Volk
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006684:HLA-DR Antigens / Q000097:blood; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D011237:Predictive Value of Tests; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D006684:HLA-DR Antigens